Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Double-Blind, Placebo Controlled, Randomized, Multicenter, Phase II Study to Assess the Efficacy of the High Affinity CXCR4 Inhibitor BL-8040 As Addition to Consolidation Therapy in AML By the SAL and OSHO Leukemia Study Groups

Sonia Jaramillo Segura, Maxi Wass, Judith Schaffrath, Kathrin Rieger, Axel Nogai, Mathias Haenel, Regina Herbst, Friedrich Stoelzel, Christoph Röllig, Edgar Jost, Richard F. Schlenk, Richard Noppeney, Christian H. Brandts, Utz Krug, Katharina S. Goetze, Sebastian Buske, Axel Florschütz, Jörg Schubert, Bernhard Opitz, Martin Mohren, Eva Eßeling, Stephan von Witzendorff, Marion Subklewe, Martin Kaufmann, Norbert Frickhofen, Christian W Scholz, Kerstin Schäfer-Eckart, Volker Kunzmann, Martin Schmidt-Hieber, Herbert G. Sayer, Andreas Rank, Philipp Hemmati, Frank Schueler, Simone Kowoll, Marina Scheller, Jörg Steighardt, Bayram Edemir, Lutz Peter Mueller, Irit Gliko-Kabir, Beatrice Ludwig-Kraus, Sabine Edemir, Ella Sorani, Mascha Binder, Abi Vainstein, Shaul Kadosh, Cora Gromann, Andreas Wienke, Claudia D. Baldus, Uwe Platzbecker, Hubert Serve, Martin Bornhaeuser, Christian Junghanss, Carsten Mueller-Tidow

Blood (2022) 140 (Supplement 1): 3338–3340.

https://doi.org/10.1182/blood-2022-166748

Published: 2022

Journal Articles

Combined Bendamustine, Prednisone and Bortezomib (BPV) in Patients with Relapsed or Refractory Multiple Myeloma

Blood (2012) 120 (21): 1855.

https://doi.org/10.1182/blood.V120.21.1855.1855

Published: 2012

Journal Articles

Combined Bendamustine, Prednisolone and Lenalidomide (RBP) In Refractory or Relapsed Multiple Myeloma. First Results of a Phase I Clinical Trial

Wolfram Pönisch, Simone Heyn, Ina Wagner, Martin Mohren, MD, Franz-Albert Hoffmann, Frank Schüler, Marion Schmalfeld, Haifa K. Al-Ali, Nadja Jäkel, Dietger W Niederwieser, MD

Blood (2010) 116 (21): 1971.

https://doi.org/10.1182/blood.V116.21.1971.1971

Published: 2010

Journal Articles

Immunochemotherapy with Rituximab Improves Molecular CR Rate and Outcome In CD20+ B-Lineage Standard and High Risk Patients; Results of 263 CD20+ Patients Studied Prospectively In GMALL Study 07/2003

Dieter Hoelzer, MD, Andreas Huettmann, MD, Felix Kaul, Sebastian Irmer, Nadja Jaekel, Martin Mohren, Thomas Lipp, Knut Wedelin, Francisco de Valle, Mathias Schmid, MD, Eckhard Thiel, Prof., Dr., Dr., h.c., Monika Brueggemann, Michael Kneba, MD, PhD, Nicola Goekbuget, MD

Blood (2010) 116 (21): 170.

https://doi.org/10.1182/blood.V116.21.170.170

Published: 2010

Journal Articles

PEG-Asparaginase Intensification In Adult Acute Lymphoblastic Leukemia (ALL): Significant Improvement of Outcome with Moderate Increase of Liver Toxicity In the German Multicenter Study Group for Adult ALL (GMALL) Study 07/2003

Nicola Goekbuget, MD, Anja Baumann, MD, Joachim Beck, MD, Monika Brueggemann, MD, Helmut Diedrich, MD, Andreas Huettmann, MD, Lothar Leimer, MD, Stefan Zewen, MD, Martin Mohren, MD, Albrecht Reichle, MD, Markus Schaich, MD, Kerstin Schaefer-Eckart, MD, Marc Schmalzing, MD, Mathias Schmid, MD, Hubert Serve, MD, Reingard Stuhlmann, MD, Theis H Terwey, MD, Dieter Hoelzer, MD

Blood (2010) 116 (21): 494.

https://doi.org/10.1182/blood.V116.21.494.494

Published: 2010

Journal Articles

PEG-Asparaginase in Adult Acute Lymphoblastic Leukemia (ALL): Efficacy and Feasibility Analysis with Increasing Dose Levels

Nicola Goekbuget, MD, Anja Baumann, MD, Joachim Beck, MD, Joachim Boos, MD, PhD, Monika Brueggemann, MD, PhD, Helmut Diedrich, MD, Andreas Hüttmann, MD, Lothar Leimer, MD, Thomas Lipp, MD, Ralph Naumann, MD, PhD, Martin Mohren, MD, Albrecht Reichle, MD, PhD, Kerstin Schäfer-Eckart, MD, Marc Schmalzing, MD, Mathias Schmid, MD, PhD, Norbert Schmitz, MD, PhD, Theis Therwey, MD, Dieter Hoelzer, MD, PhD

Blood (2008) 112 (11): 302.

https://doi.org/10.1182/blood.V112.11.302.302

Published: 2008

Journal Articles

Immunochemotherapy (R-MCP) Is Not Superior to Chemotherapy (MCP) Alone in Advanced Mantle Cell Lymphoma - 42 Months Follow Up Results of the OSHO 39 Study.

Michael Herold, MD, Antje Haas, MD, Stephanie Srock, MD, Sabine Neser, MD, Kathrin H. Al Ali, MD, Andreas Neubauer, MD, Gottfried Doelken, MD, Ralph Naumann, MD, Thomas Fietz, MD, Mathias Freund, MD, Robert Rohrberg, MD, Klaus Hoeffken, MD, Martin Mohren, MD, Thomas H. Ittel, MD, Erika Kettner, MD

Blood (2007) 110 (11): 4474.

https://doi.org/10.1182/blood.V110.11.4474.4474

Published: 2007

Journal Articles

Response Adapted Assignment of the Number of Chemotherapy Cycles for the Treatment of Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Is Not Justified: Results of the RICOVER-60 Trial of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL).

Blood (2007) 110 (11): 788.

https://doi.org/10.1182/blood.V110.11.788.788

Published: 2007

Journal Articles

Tumor Burden Related Immunodeficiency in Lymphoma Patients and Clinical Course.

Kathleen Jentsch-Ullrich, MD, Annegret Gerber, MD, Regina Reppin, MD, Michael Koenigsmann, MD, PhD, Martin Mohren, MD, Astrid Franke

Blood (2005) 106 (11): 4649.

https://doi.org/10.1182/blood.V106.11.4649.4649

Published: 2005

Journal Articles

Increased Risk for Venous Thromboembolism in Patients with Acute Leukemia.

Martin Mohren, MD, Ilka Markmann, Kathleen Jentsch-Ullrich, MD, Michael Koenigsmann, MD, Gerd Lutze, MD, Astrid Franke, MD

Blood (2005) 106 (11): 4555.

https://doi.org/10.1182/blood.V106.11.4555.4555

Published: 2005

Journal Articles

Cellular Immunodeficiency in Untreated Lymphoma Patients.

Kathleen Jentsch-Ullrich, MD, Annegret Gerber, MD, Regina Reppin, MD, Michael Koenigsmann, MD, Martin Mohren, MD, Astrid Franke, MD

Blood (2004) 104 (11): 4555.

https://doi.org/10.1182/blood.V104.11.4555.4555

Published: 2004

Journal Articles

Increased Risk for Thromboembolism Associated with High Coagulation Factor VIII (F VIII) Levels in Patients with Malignant Lymphoma.

Martin Mohren, MD, Ilka Markmann, Astrid Franke, MD, Kathleen Jentsch-Ullrich, MD, Michael Koenigsmann, MD, Gerd Lutze, MD

Blood (2004) 104 (11): 1380.

https://doi.org/10.1182/blood.V104.11.1380.1380

Published: 2004

NARROW

Double-Blind, Placebo Controlled, Randomized, Multicenter, Phase II Study to Assess the Efficacy of the High Affinity CXCR4 Inhibitor BL-8040 As Addition to Consolidation Therapy in AML By the SAL and OSHO Leukemia Study Groups

Combined Bendamustine, Prednisone and Bortezomib (BPV) in Patients with Relapsed or Refractory Multiple Myeloma

Combined Bendamustine, Prednisolone and Lenalidomide (RBP) In Refractory or Relapsed Multiple Myeloma. First Results of a Phase I Clinical Trial

Immunochemotherapy with Rituximab Improves Molecular CR Rate and Outcome In CD20+ B-Lineage Standard and High Risk Patients; Results of 263 CD20+ Patients Studied Prospectively In GMALL Study 07/2003

PEG-Asparaginase Intensification In Adult Acute Lymphoblastic Leukemia (ALL): Significant Improvement of Outcome with Moderate Increase of Liver Toxicity In the German Multicenter Study Group for Adult ALL (GMALL) Study 07/2003

PEG-Asparaginase in Adult Acute Lymphoblastic Leukemia (ALL): Efficacy and Feasibility Analysis with Increasing Dose Levels

Immunochemotherapy (R-MCP) Is Not Superior to Chemotherapy (MCP) Alone in Advanced Mantle Cell Lymphoma - 42 Months Follow Up Results of the OSHO 39 Study.

Response Adapted Assignment of the Number of Chemotherapy Cycles for the Treatment of Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Is Not Justified: Results of the RICOVER-60 Trial of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL).

Tumor Burden Related Immunodeficiency in Lymphoma Patients and Clinical Course.

Increased Risk for Venous Thromboembolism in Patients with Acute Leukemia.

Cellular Immunodeficiency in Untreated Lymphoma Patients.

Increased Risk for Thromboembolism Associated with High Coagulation Factor VIII (F VIII) Levels in Patients with Malignant Lymphoma.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only